Bridgewater Associates’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,100
Closed -$298K 890
2024
Q1
$298K Sell
1,100
-1,665
-60% -$451K ﹤0.01% 655
2023
Q4
$654K Sell
2,765
-240
-8% -$56.7K ﹤0.01% 679
2023
Q3
$589K Sell
3,005
-1,301
-30% -$255K ﹤0.01% 674
2023
Q2
$905K Buy
4,306
+1,124
+35% +$236K 0.01% 586
2023
Q1
$642K Sell
3,182
-263
-8% -$53.1K ﹤0.01% 614
2022
Q4
$751K Buy
3,445
+1,392
+68% +$303K ﹤0.01% 677
2022
Q3
$404K Sell
2,053
-3,553
-63% -$699K ﹤0.01% 798
2022
Q2
$1.2M Buy
5,606
+666
+13% +$143K 0.01% 769
2022
Q1
$1.4M Buy
4,940
+3,453
+232% +$981K 0.01% 755
2021
Q4
$560K Buy
1,487
+838
+129% +$316K ﹤0.01% 637
2021
Q3
$268K Buy
+649
New +$268K ﹤0.01% 647
2019
Q4
Sell
-3,406
Closed -$451K 499
2019
Q3
$451K Buy
+3,406
New +$451K ﹤0.01% 283
2019
Q1
Sell
-15,166
Closed -$1.72M 354
2018
Q4
$1.72M Buy
15,166
+12,120
+398% +$1.37M 0.02% 261
2018
Q3
$410K Sell
3,046
-7,459
-71% -$1M ﹤0.01% 298
2018
Q2
$1.18M Sell
10,505
-1,740
-14% -$195K 0.01% 235
2018
Q1
$1.31M Buy
+12,245
New +$1.31M 0.01% 236
2017
Q4
Sell
-2,574
Closed -$278K 265
2017
Q3
$278K Sell
2,574
-4,135
-62% -$447K ﹤0.01% 275
2017
Q2
$679K Buy
+6,709
New +$679K 0.01% 233
2016
Q1
Sell
-2,687
Closed -$216K 268
2015
Q4
$216K Sell
2,687
-17,000
-86% -$1.37M ﹤0.01% 254
2015
Q3
$1.25M Buy
+19,687
New +$1.25M 0.02% 222
2015
Q2
Sell
-4,700
Closed -$373K 330
2015
Q1
$373K Sell
4,700
-500
-10% -$39.7K ﹤0.01% 264
2014
Q4
$331K Buy
5,200
+1,000
+24% +$63.7K ﹤0.01% 278
2014
Q3
$251K Buy
+4,200
New +$251K ﹤0.01% 339